Literature DB >> 17826313

Transmission of hepatitis B virus (genotype E) in a haemodialysis unit.

Sandeep Ramalingam1, Teresa Leung, Hugh Cairns, Paula Sibley, Melvyn Smith, Samreen Ijaz, Richard Tedder, Mark Zuckerman.   

Abstract

BACKGROUND: The Rosenheim report, published in 1972, was aimed at decreasing the transmission of hepatitis B virus (HBV) in the renal unit. A review in 1996, revealed the non-compliance of some centres with the guidance to vaccinate individuals against HBV.
OBJECTIVES: To describe two events of acute hepatitis B virus (HBV) infection within 9 weeks in individuals attending the renal unit and the steps taken to prevent further transmission. STUDY
DESIGN: Serological and molecular testing was carried out on the two individuals with acute HBV and other HBV carriers in the unit. Epidemiological information was collected along with information on HBV vaccination and HBsAg screening.
RESULTS: There were 15 known HBV carriers in the unit. HBV genotype E was transmitted from a carrier to patient 1 when they were in the same ward. Transmission to patient 2 occurred when he followed patient 1 on the theatre list. Breaks in infection control were identified and steps were taken to prevent further transmission events.
CONCLUSIONS: Breaks in infection control procedures were rectified. No further transmission of HBV was identified. This highlights the need for vigilance regarding infection control practices in the renal unit setting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826313     DOI: 10.1016/j.jcv.2007.07.012

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  2 in total

1.  Guidelines for the detection of a common source of hepatitis B virus infections.

Authors:  Mahmoud Reza Pourkarim; Marc Van Ranst
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

2.  Clinical practice guideline management of blood borne viruses within the haemodialysis unit.

Authors:  Elizabeth Garthwaite; Veena Reddy; Sam Douthwaite; Simon Lines; Kay Tyerman; James Eccles
Journal:  BMC Nephrol       Date:  2019-10-28       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.